BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34084020)

  • 1. Idiopathic Guttate Hypomelanosis Treated with 308-nm Excimer Light and Topical Bimatoprost.
    Kreeshan FC; Madan V
    J Cutan Aesthet Surg; 2021; 14(1):115-117. PubMed ID: 34084020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study.
    Gordon JR; Reed KE; Sebastian KR; Ahmed AM
    Dermatol Surg; 2017 Apr; 43(4):553-557. PubMed ID: 27930376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic wounding - 88% phenol in idiopathic guttate hypomelanosis.
    Ravikiran SP; Sacchidanand S; Leelavathy B
    Indian Dermatol Online J; 2014 Jan; 5(1):14-8. PubMed ID: 24616848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypopigmented macules of photodamaged skin and their treatment with topical tretinoin.
    Pagnoni A; Kligman AM; Sadiq I; Stoudemayer T
    Acta Derm Venereol; 1999 Jul; 79(4):305-10. PubMed ID: 10429990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the pathogenesis of idiopathic guttate hypomelanosis.
    Falabella R; Escobar C; Giraldo N; Rovetto P; Gil J; Barona MI; Acosta F; Alzate A
    J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):35-44. PubMed ID: 3805391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of non-ablative fractional photothermolysis and 0.1% tacrolimus ointment is efficacious for treating idiopathic guttate hypomelanosis.
    Chitvanich S; Rerknimitr P; Panchaprateep R; Pongprutthipan M; Asawanonda P
    J Dermatolog Treat; 2016 Oct; 27(5):456-60. PubMed ID: 26864301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic guttate hypomelanosis: Presentation and Management.
    Buch J; Patil A; Kroumpouzos G; Kassir M; Galadari H; Gold MH; Goldman MP; Grabbe S; Goldust M
    J Cosmet Laser Ther; 2021 Feb; 23(1-2):8-15. PubMed ID: 34304679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic Guttate Hypomelanosis: A Review of its Etiology, Pathogenesis, Findings, and Treatments.
    Juntongjin P; Laosakul K
    Am J Clin Dermatol; 2016 Aug; 17(4):403-11. PubMed ID: 27206417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermoscopic evaluation of idiopathic guttate hypomelanosis: A preliminary observation.
    Ankad BS; Beergouder SL
    Indian Dermatol Online J; 2015; 6(3):164-7. PubMed ID: 26009709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pimecrolimus for idiopathic guttate hypomelanosis.
    Asawanonda P; Sutthipong T; Prejawai N
    J Drugs Dermatol; 2010 Mar; 9(3):238-9. PubMed ID: 20232585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study between excimer light and topical antioxidant versus excimer light alone for treatment of vitiligo.
    Soliman M; Samy NA; Abo Eittah M; Hegazy M
    J Cosmet Laser Ther; 2016; 18(1):7-11. PubMed ID: 26052813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repigmentation of hypopigmented scars using an erbium-doped 1,550-nm fractionated laser and topical bimatoprost.
    Massaki AB; Fabi SG; Fitzpatrick R
    Dermatol Surg; 2012 Jul; 38(7 Pt 1):995-1001. PubMed ID: 22540767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive macular hypomelanosis in korean patients: a clinicopathologic study.
    Hwang SW; Hong SK; Kim SH; Park JH; Seo JK; Sung HS; Lee D
    Ann Dermatol; 2009 Aug; 21(3):261-7. PubMed ID: 20523800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of idiopathic guttate hypomelanosis with fractional carbon dioxide lasers.
    Goldust M; Mohebbipour A; Mirmohammadi R
    J Cosmet Laser Ther; 2013 May; ():. PubMed ID: 23656568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study.
    Shah S; Sakhiya J; Deshpande P; Sakhiya D; Inamadar AC
    J Clin Aesthet Dermatol; 2020 Feb; 13(2):E69-E75. PubMed ID: 32308788
    [No Abstract]   [Full Text] [Related]  

  • 16. Idiopathic guttate hypomelanosis.
    Savall R; Ferrandiz C; Ferrer I; Peyri J
    Br J Dermatol; 1980 Dec; 103(6):635-42. PubMed ID: 6779850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo following intense pulsed light treatment.
    Shin JU; Roh MR; Lee JH
    J Dermatol; 2010 Jul; 37(7):674-6. PubMed ID: 20629836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic guttate hypomelanosis-like lesions in patients with mycosis fungoides: a new adverse effect of phototherapy.
    Friedland R; David M; Feinmesser M; Fenig-Nakar S; Hodak E
    J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):1026-30. PubMed ID: 20180893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and relapse rates of different treatment modalities for progressive macular hypomelanosis.
    Thng ST; Long VS; Chuah SY; Tan VW
    Indian J Dermatol Venereol Leprol; 2016; 82(6):673-676. PubMed ID: 27212282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic findings of guttate leukoderma in Darier disease: A helpful diagnostic feature.
    Harb JN; Motaparthi K
    JAAD Case Rep; 2018 Apr; 4(3):262-266. PubMed ID: 29687067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.